117 related articles for article (PubMed ID: 25224916)
1. Association of H3K9me3 and H3K27me3 repressive histone marks with breast cancer subtypes in the Nurses' Health Study.
Healey MA; Hu R; Beck AH; Collins LC; Schnitt SJ; Tamimi RM; Hazra A
Breast Cancer Res Treat; 2014 Oct; 147(3):639-51. PubMed ID: 25224916
[TBL] [Abstract][Full Text] [Related]
2. Survival is associated with repressive histone trimethylation markers in both HR-positive HER2-negative and triple-negative breast cancer patients.
Wang B; Zhou M; Shi YY; Chen XL; Ren YX; Yang YZ; Tang LY; Ren ZF
Virchows Arch; 2023 Jun; 482(6):1047-1056. PubMed ID: 37059917
[TBL] [Abstract][Full Text] [Related]
3. Analysis of H3K4me3 and H3K27me3 bivalent promotors in HER2+ breast cancer cell lines reveals variations depending on estrogen receptor status and significantly correlates with gene expression.
Kaukonen D; Kaukonen R; Polit L; Hennessy BT; Lund R; Madden SF
BMC Med Genomics; 2020 Jul; 13(1):92. PubMed ID: 32620123
[TBL] [Abstract][Full Text] [Related]
4. Association of poor prognosis subtypes of breast cancer with estrogen receptor alpha methylation in Iranian women.
Izadi P; Mehrdad N; Foruzandeh F; Reza NM
Asian Pac J Cancer Prev; 2012; 13(8):4113-7. PubMed ID: 23098526
[TBL] [Abstract][Full Text] [Related]
5. Comparison of breast cancer risk factors among molecular subtypes: A case-only study.
Zhang L; Huang Y; Feng Z; Wang X; Li H; Song F; Liu L; Li J; Zheng H; Wang P; Song F; Chen K
Cancer Med; 2019 Apr; 8(4):1882-1892. PubMed ID: 30761775
[TBL] [Abstract][Full Text] [Related]
6. Parity, hormones and breast cancer subtypes - results from a large nested case-control study in a national screening program.
Ellingjord-Dale M; Vos L; Tretli S; Hofvind S; Dos-Santos-Silva I; Ursin G
Breast Cancer Res; 2017 Jan; 19(1):10. PubMed ID: 28114999
[TBL] [Abstract][Full Text] [Related]
7. Methylation Patterns of Lys9 and Lys27 on Histone H3 Correlate with Patient Outcome in Gastric Cancer.
Li Y; Guo D; Sun R; Chen P; Qian Q; Fan H
Dig Dis Sci; 2019 Feb; 64(2):439-446. PubMed ID: 30350241
[TBL] [Abstract][Full Text] [Related]
8. Reproductive risk factors in relation to molecular subtypes of breast cancer: Results from the nurses' health studies.
Sisti JS; Collins LC; Beck AH; Tamimi RM; Rosner BA; Eliassen AH
Int J Cancer; 2016 May; 138(10):2346-56. PubMed ID: 26684063
[TBL] [Abstract][Full Text] [Related]
9. Reproductive behaviors and risk of developing breast cancer according to tumor subtype: A systematic review and meta-analysis of epidemiological studies.
Lambertini M; Santoro L; Del Mastro L; Nguyen B; Livraghi L; Ugolini D; Peccatori FA; Azim HA
Cancer Treat Rev; 2016 Sep; 49():65-76. PubMed ID: 27529149
[TBL] [Abstract][Full Text] [Related]
10. Parity, breastfeeding, and breast cancer risk by hormone receptor status and molecular phenotype: results from the Nurses' Health Studies.
Fortner RT; Sisti J; Chai B; Collins LC; Rosner B; Hankinson SE; Tamimi RM; Eliassen AH
Breast Cancer Res; 2019 Mar; 21(1):40. PubMed ID: 30867002
[TBL] [Abstract][Full Text] [Related]
11. Breast MRI background parenchymal enhancement as an imaging bridge to molecular cancer sub-type.
Dilorenzo G; Telegrafo M; La Forgia D; Stabile Ianora AA; Moschetta M
Eur J Radiol; 2019 Apr; 113():148-152. PubMed ID: 30927939
[TBL] [Abstract][Full Text] [Related]
12. Pooled Analysis of Nine Cohorts Reveals Breast Cancer Risk Factors by Tumor Molecular Subtype.
Gaudet MM; Gierach GL; Carter BD; Luo J; Milne RL; Weiderpass E; Giles GG; Tamimi RM; Eliassen AH; Rosner B; Wolk A; Adami HO; Margolis KL; Gapstur SM; Garcia-Closas M; Brinton LA
Cancer Res; 2018 Oct; 78(20):6011-6021. PubMed ID: 30185547
[TBL] [Abstract][Full Text] [Related]
13. Alcohol consumption and risk of breast cancer by molecular subtype: Prospective analysis of the nurses' health study after 26 years of follow-up.
Hirko KA; Chen WY; Willett WC; Rosner BA; Hankinson SE; Beck AH; Tamimi RM; Eliassen AH
Int J Cancer; 2016 Mar; 138(5):1094-101. PubMed ID: 26384849
[TBL] [Abstract][Full Text] [Related]
14. Anthropometric factors and risk of molecular breast cancer subtypes among postmenopausal Norwegian women.
Horn J; Alsaker MD; Opdahl S; Engstrøm MJ; Tretli S; Haugen OA; Bofin AM; Vatten LJ; Asvold BO
Int J Cancer; 2014 Dec; 135(11):2678-86. PubMed ID: 24752603
[TBL] [Abstract][Full Text] [Related]
15. [Clinical characteristics and survival in the operable breast cancer patients with different molecular subtypes].
Zhang HM; Zhang BN; Xuan LX; Zhao P
Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):447-51. PubMed ID: 19950556
[TBL] [Abstract][Full Text] [Related]
16. Erythrocyte membrane fatty acids and breast cancer risk by tumor tissue expression of immuno-inflammatory markers and fatty acid synthase: a nested case-control study.
McGee EE; Kim CH; Wang M; Spiegelman D; Stover DG; Heng YJ; Collins LC; Baker GM; Farvid MS; Schedin P; Jindal S; Tamimi RM; Eliassen AH
Breast Cancer Res; 2020 Jul; 22(1):78. PubMed ID: 32698885
[TBL] [Abstract][Full Text] [Related]
17. A retrospective study of breast cancer subtypes: the risk of relapse and the relations with treatments.
Wang Y; Yin Q; Yu Q; Zhang J; Liu Z; Wang S; Lv S; Niu Y
Breast Cancer Res Treat; 2011 Nov; 130(2):489-98. PubMed ID: 21837481
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) among women with invasive breast cancer in California, 1999-2004.
Parise CA; Bauer KR; Brown MM; Caggiano V
Breast J; 2009; 15(6):593-602. PubMed ID: 19764994
[TBL] [Abstract][Full Text] [Related]
19. Presenting features of breast cancer differ by molecular subtype.
Wiechmann L; Sampson M; Stempel M; Jacks LM; Patil SM; King T; Morrow M
Ann Surg Oncol; 2009 Oct; 16(10):2705-10. PubMed ID: 19593632
[TBL] [Abstract][Full Text] [Related]
20. Digital imaging-assisted quantification of H3K27me3 immunoexpression in luminal A/B-like, HER2-negative, invasive breast cancer predicts patient survival and risk of recurrence.
Fontes-Sousa M; Lobo J; Lobo S; Salta S; Amorim M; Lopes P; Antunes L; de Sousa SP; Henrique R; Jerónimo C
Mol Med; 2020 Feb; 26(1):22. PubMed ID: 32050892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
